| Product Code: ETC10132368 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zimbabwe Antimicrobial Resistance Market Overview |
3.1 Zimbabwe Country Macro Economic Indicators |
3.2 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Zimbabwe Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Zimbabwe Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Zimbabwe Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Zimbabwe Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Zimbabwe Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Zimbabwe Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Zimbabwe Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Zimbabwe |
4.2.2 Growing awareness about the importance of antimicrobial resistance |
4.2.3 Investments in healthcare infrastructure and research and development |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 Lack of regulatory framework for antimicrobial use and stewardship |
4.3.3 High cost of antimicrobial resistance treatments |
5 Zimbabwe Antimicrobial Resistance Market Trends |
6 Zimbabwe Antimicrobial Resistance Market, By Types |
6.1 Zimbabwe Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Zimbabwe Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Zimbabwe Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Zimbabwe Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Zimbabwe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Zimbabwe Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Zimbabwe Antimicrobial Resistance Market Export to Major Countries |
7.2 Zimbabwe Antimicrobial Resistance Market Imports from Major Countries |
8 Zimbabwe Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities with antimicrobial stewardship programs |
8.2 Number of reported cases of antimicrobial-resistant infections |
8.3 Investment in research and development for new antimicrobial drugs |
9 Zimbabwe Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Zimbabwe Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Zimbabwe Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Zimbabwe Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Zimbabwe Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Zimbabwe Antimicrobial Resistance Market - Competitive Landscape |
10.1 Zimbabwe Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Zimbabwe Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here